T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Airlines Group
AAL
|
+$1.21B |
| 2 |
RTX Corp
RTX
|
+$1.14B |
| 3 |
PepsiCo
PEP
|
+$1.12B |
| 4 |
ASML
ASML
|
+$817M |
| 5 |
Wynn Resorts
WYNN
|
+$798M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Mastercard
MA
|
+$1.08B |
| 3 |
Qualcomm
QCOM
|
+$972M |
| 4 |
eBay
EBAY
|
+$898M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$748M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.86% |
| 2 | Consumer Discretionary | 13.55% |
| 3 | Financials | 13.21% |
| 4 | Industrials | 12.32% |
| 5 | Technology | 9.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Douglas Emmett
DEI
$1.95B
| $170M | 0.04% |
6,258,402
+202,530
| +3% | +$5.24M |
|
477
PVH
PVH
$3.76B
| $169M | 0.04% |
1,354,102
-902,994
| -40% | -$111M |
|
478
Regency Centers
REG
$13.9B
| $169M | 0.04% |
3,306,090
+226,213
| +7% | +$11.1M |
|
|
FLTX
479
DELISTED
Fleetmatics Group PLC
FLTX
| $167M | 0.04% |
5,003,260
+1,843,660
| +58% | +$69.8M |
|
480
M&T Bank
MTB
$36.6B
| $167M | 0.04% |
1,377,527
+1,077,238
| +359% | +$124M |
|
|
DNKN
481
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $167M | 0.04% |
3,328,100
+1,029,300
| +45% | +$50.8M |
|
482
Kirby Corp
KEX
$7.18B
| $167M | 0.04% |
1,648,183
-46,827
| -3% | -$4.72M |
|
483
Neurocrine Biosciences
NBIX
$15.9B
| $165M | 0.04% |
10,256,939
+945,000
| +10% | +$16.2M |
|
484
Pool Corp
POOL
$7.25B
| $165M | 0.04% |
2,691,329
-87,840
| -3% | -$5.05M |
|
|
OPEN
485
DELISTED
OPENTABLE,INC COMMON STOCK
OPEN
| $165M | 0.04% |
2,142,910
-161,210
| -7% | -$12.7M |
|
486
Colgate-Palmolive
CL
$73.6B
| $165M | 0.04% |
2,536,375
+45,713
| +2% | +$2.88M |
|
487
Home BancShares
HOMB
$6.23B
| $164M | 0.04% |
9,554,676
-206,800
| -2% | -$3.48M |
|
488
Caterpillar
CAT
$393B
| $163M | 0.04% |
1,643,966
-476,500
| -22% | -$44.9M |
|
489
Southwest Gas
SWX
$6.68B
| $163M | 0.04% |
3,041,210
-5,710
| -0.2% | -$307K |
|
|
MHFI
490
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $159M | 0.04% |
2,089,474
-3,393,467
| -62% | -$265M |
|
|
MDCO
491
DELISTED
Medicines Co
MDCO
| $159M | 0.04% |
5,597,295
-244,420
| -4% | -$8.09M |
|
|
AEGR
492
DELISTED
Aegerion Pharmaceuticals
AEGR
| $159M | 0.04% |
3,439,653
-418,547
| -11% | -$24.5M |
|
|
HBI
493
DELISTED
Hanesbrands
HBI
| $158M | 0.04% |
8,271,788
+6,687,988
| +422% | +$120M |
|
|
NBIS
494
Nebius Group N.V.
NBIS
$65.8B
| $158M | 0.04% |
5,235,195
+2,119,300
| +68% | +$78.2M |
|
495
Graco
GGG
$13.4B
| $157M | 0.04% |
6,307,608
+1,991,352
| +46% | +$49.8M |
|
496
BioMarin Pharmaceuticals
BMRN
$13.6B
| $157M | 0.04% |
2,299,949
-376,976
| -14% | -$27.8M |
|
497
Altria Group
MO
$107B
| $157M | 0.04% |
4,189,894
+112,609
| +3% | +$4.09M |
|
498
Carpenter Technology
CRS
$26.3B
| $157M | 0.04% |
2,374,172
+3,603
| +0.2% | +$217K |
|
499
Lam Research
LRCX
$408B
| $156M | 0.04% |
28,448,730
+20,840,130
| +274% | +$111M |
|
|
RAVN
500
DELISTED
Raven Industries Inc
RAVN
| $155M | 0.03% |
4,745,900
-600
| -0% | -$21.8K |
|
Similar funds
T. Rowe Price Associates's Q1 2014 Portfolio in Review
As of Q1 2014, T. Rowe Price Associates held 2,567 positions worth $445B, up 2% from $436B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q1 2014 filing shows 89 new, 904 increased, 825 reduced and 68 closed positions. Its largest new stake was Liberty Global Class C: 13,695,496 shares worth $451M. The largest sale was Apple, an estimated $1.24B.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2014 buy was Liberty Global Class C: 13,695,496 shares worth $451M.
- T. Rowe Price Associates added most to American Airlines Group in Q1 2014, an estimated $1.21B increase.
- T. Rowe Price Associates's biggest Q1 2014 reduction was Apple, cutting an estimated $1.24B.
- T. Rowe Price Associates fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $200M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $445B portfolio in Q1 2014.
- T. Rowe Price Associates opened 89 new positions and closed 68 in Q1 2014.
- T. Rowe Price Associates's portfolio value rose 2% quarter-over-quarter to $445B.
Based on T. Rowe Price Associates's 13F filing for Q1 2014, filed 15 May 2014.